CHO Pharma, Inc. (TPEX:6586)
Taiwan
· Delayed Price · Currency is TWD 43.10
-1.40 (-3.15%)
Apr 24, 2025, 1:54 PM CST
CHO Pharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 21.81 | 203.79 | 505.66 | 777.98 | 986.39 | Upgrade
|
| Short-Term Investments | 2,344 | 2,399 | 538.9 | 538.9 | 538.9 | Upgrade
|
| Cash & Short-Term Investments | 2,366 | 2,603 | 1,045 | 1,317 | 1,525 | Upgrade
|
| Cash Growth | -9.10% | 149.17% | -20.68% | -13.66% | -15.42% | Upgrade
|
| Accounts Receivable | 0.75 | - | - | 0.06 | - | Upgrade
|
| Other Receivables | 5.05 | 2.09 | 0.09 | 0.08 | 0.09 | Upgrade
|
| Receivables | 5.8 | 2.09 | 0.09 | 0.14 | 0.09 | Upgrade
|
| Other Current Assets | 45.68 | 38.23 | 34.8 | 23.62 | 21.29 | Upgrade
|
| Total Current Assets | 2,417 | 2,643 | 1,079 | 1,341 | 1,547 | Upgrade
|
| Property, Plant & Equipment | 36.43 | 8.2 | 19.74 | 37.23 | 62.51 | Upgrade
|
| Other Intangible Assets | 424.8 | 431.8 | 497.23 | 509.93 | 528.63 | Upgrade
|
| Other Long-Term Assets | 2.67 | 3.02 | 5.84 | 5.91 | 5.15 | Upgrade
|
| Total Assets | 2,881 | 3,086 | 1,602 | 1,894 | 2,143 | Upgrade
|
| Accrued Expenses | 95.75 | 99.43 | 150.85 | 113.04 | 130.38 | Upgrade
|
| Current Portion of Leases | 14.31 | - | 11.7 | 13.87 | 12.59 | Upgrade
|
| Other Current Liabilities | 6.12 | 6.6 | 6.35 | 6.31 | 6.23 | Upgrade
|
| Total Current Liabilities | 116.19 | 106.03 | 168.9 | 133.22 | 149.2 | Upgrade
|
| Long-Term Leases | 14.59 | - | - | 11.7 | 25.67 | Upgrade
|
| Other Long-Term Liabilities | 1.8 | 4.8 | 4.8 | 4.8 | 4.8 | Upgrade
|
| Total Liabilities | 132.58 | 110.83 | 173.7 | 149.71 | 179.67 | Upgrade
|
| Common Stock | 2,140 | 2,140 | 1,840 | 1,839 | 1,838 | Upgrade
|
| Additional Paid-In Capital | 1,130 | 1,688 | 135.73 | 410.58 | 782.73 | Upgrade
|
| Retained Earnings | -518.31 | -850.41 | -544.32 | -502.76 | -655.21 | Upgrade
|
| Comprehensive Income & Other | -2.7 | -2.75 | -2.79 | -3.25 | -2.53 | Upgrade
|
| Shareholders' Equity | 2,749 | 2,975 | 1,429 | 1,744 | 1,963 | Upgrade
|
| Total Liabilities & Equity | 2,881 | 3,086 | 1,602 | 1,894 | 2,143 | Upgrade
|
| Total Debt | 28.9 | - | 11.7 | 25.56 | 38.26 | Upgrade
|
| Net Cash (Debt) | 2,337 | 2,603 | 1,033 | 1,291 | 1,487 | Upgrade
|
| Net Cash Growth | -10.21% | 151.99% | -20.02% | -13.16% | -15.65% | Upgrade
|
| Net Cash Per Share | 10.92 | 13.60 | 5.61 | 7.02 | 8.10 | Upgrade
|
| Filing Date Shares Outstanding | 214.01 | 214.01 | 183.99 | 183.94 | 183.68 | Upgrade
|
| Total Common Shares Outstanding | 214.01 | 214.01 | 183.99 | 183.94 | 183.68 | Upgrade
|
| Working Capital | 2,301 | 2,537 | 910.56 | 1,207 | 1,397 | Upgrade
|
| Book Value Per Share | 12.84 | 13.90 | 7.76 | 9.48 | 10.69 | Upgrade
|
| Tangible Book Value | 2,324 | 2,543 | 931.34 | 1,234 | 1,435 | Upgrade
|
| Tangible Book Value Per Share | 10.86 | 11.88 | 5.06 | 6.71 | 7.81 | Upgrade
|
| Machinery | 112.08 | 107.99 | 104.61 | 96.59 | 95.3 | Upgrade
|
| Leasehold Improvements | 20.72 | 20.38 | 19.82 | 18.6 | 18.66 | Upgrade
|
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.